Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
September 30, 2026 -67.05M
June 30, 2026 24.07M
March 31, 2026 7.362M
December 31, 2025 19.55M
September 30, 2025 -63.70M
June 30, 2025 9.039M
March 31, 2025 -15.04M
December 31, 2024 19.04M
September 30, 2024 14.81M
June 30, 2024 1.255M
March 31, 2024 -76.68M
December 31, 2023 18.96M
September 30, 2023 20.14M
June 30, 2023 70.15M
Date Value
March 31, 2023 -27.30M
December 31, 2022 -30.18M
September 30, 2022 -78.72M
June 30, 2022 -11.22M
March 31, 2022 -6.857M
December 31, 2021 -8.316M
September 30, 2021 -6.82M
June 30, 2021 -43.36M
March 31, 2021 -8.876M
December 31, 2020 -0.91M
September 30, 2020 -0.735M
June 30, 2020 -0.337M
March 31, 2020 -0.189M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Twist Bioscience Corp. -20.25M
Moderna, Inc. -1.715B
Tenax Therapeutics, Inc. 0.00
Exicure, Inc. 0.00
Recursion Pharmaceuticals, Inc. -0.407M